Document is current
Any future updates will be listed below
-
Authors
Zigo, Michal https://orcid.org/0000-0002-2964-5940
Kerns, Karl
Sen, Sidharth https://orcid.org/0000-0002-9196-204X
Essien, Clement https://orcid.org/0000-0003-1876-8889
Oko, Richard
Xu, Dong https://orcid.org/0000-0002-4809-0514
Sutovsky, Peter https://orcid.org/0000-0002-9231-2823
-
Funding
Funding for this research was provided by:
University of Missouri (CAFNR Joy of Discovery Seed Grant award, CAFNR Joy of Discovery Seed Grant award)
United States Department of Agriculture | Agricultural Research Service (2019-67012-29714, 2020-67015-31017, 2021-67015-33404)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM126985, R35GM126985)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
- License Information
-
More Information
Article History
Received: 8 October 2021
Accepted: 12 May 2022
First Online: 3 June 2022
Competing interests
: There is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported. It is disclosed that P.S. and K.K. are the founders and owners of AndroLabb LLC, Columbia, MO, a biotech startup involved with sperm processing and sperm quality diagnostics, which did not play any role in the trials described herein.
